Browse Pet Safety Reports
143,870 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 143,870 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 143,870 FDA veterinary adverse event reports for Cat.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Dec 13, 2024 | Cat | Domestic Shorthair | Protamine Zinc Recombinant Human Insulin | Lack of efficacy - NOS | Outcome Unknown |
| Dec 13, 2024 | Cat | Domestic Longhair | Velagliflozin Proline Monohydrate | Lack of efficacy - NOS | Outcome Unknown |
| Dec 13, 2024 | Cat | Domestic Shorthair | Mirtazapine | Lack of efficacy - NOS | Recovered/Normal |
| Dec 13, 2024 | Cat | Domestic Longhair | Frunevetmab | Injection site mass NOS; Injection site haematoma | Recovered/Normal |
| Dec 13, 2024 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Dec 13, 2024 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Ketosis; Ketonuria | Ongoing |
| Dec 13, 2024 | Cat | Domestic Longhair | Eprinomectin; Praziquantel; Esafoxolaner | Excessive thirst; Agitation | Outcome Unknown |
| Dec 13, 2024 | Cat | Domestic Mediumhair | Eprinomectin; Praziquantel; Esafoxolaner | Lack of efficacy (endoparasite) - roundworm NOS | Outcome Unknown |
| Dec 13, 2024 | Cat | Domestic Shorthair | Buprenorphine | Application site alopecia | Ongoing |
| Dec 13, 2024 | Cat | Persian | Florfenicol, Terbinafine, Betamethaso... | Horner's syndrome; Eye disorder NOS (for Photophobia see neurological); Not e... | Outcome Unknown |
| Dec 13, 2024 | Cat | Domestic Shorthair | Oclacitinib Maleate | Hyperglycaemia; Hypokalaemia; Elevated serum alkaline phosphatase (ALP); Thir... | Ongoing |
| Dec 13, 2024 | Cat | Cat (unknown) | Buprenorphine | Dysphoria; Elevated temperature | Recovered/Normal; Outcome Unknown |
| Dec 13, 2024 | Cat | Domestic Mediumhair | Selamectin;Sarolaner | Application site erythema; Application site hair loss; Application site skin ... | Ongoing |
| Dec 13, 2024 | Cat | Domestic Shorthair | Sarolaner | Intentional misuse; Lethargy (see also Central nervous system depression in N... | Ongoing |
| Dec 13, 2024 | Cat | Domestic Shorthair | Praziquantel; Emodepside | Restlessness | Ongoing |
| Dec 13, 2024 | Cat | Domestic Shorthair | Buprenorphine | Recumbency; Decreased body temperature; Low blood pressure; Sleepiness - syst... | Ongoing |
| Dec 13, 2024 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Drooling | Recovered/Normal |
| Dec 13, 2024 | Cat | American Shorthair | Robenacoxib | Constipation; Pain NOS | Ongoing |
| Dec 13, 2024 | Cat | Domestic Shorthair | Mirtazapine | Lack of efficacy - NOS | Outcome Unknown |
| Dec 13, 2024 | Cat | Cat (other) | Maropitant Citrate | Intentional misuse; Wheezing; Laboured breathing | Ongoing |
| Dec 13, 2024 | Cat | Domestic Mediumhair | Neomycin Sulfate; Thiabendazole; Dexa... | Vomiting | Recovered/Normal |
| Dec 13, 2024 | Cat | American Shorthair | Robenacoxib | Panic; Ataxia; Dilated pupils; Knuckling; Other abnormal test result NOS | Ongoing |
| Dec 13, 2024 | Cat | Domestic Mediumhair | Maropitant Citrate | Anorexia; Lethargy (see also Central nervous system depression in Neurologica... | Ongoing |
| Dec 13, 2024 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Diarrhoea | Outcome Unknown |
| Dec 13, 2024 | Cat | Persian | Fluralaner Spot-On Solution | Pruritus; Hyperactivity; Hiding | Recovered/Normal |
| Dec 13, 2024 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Lack of efficacy (endoparasite) - roundworm NOS | Recovered/Normal |
| Dec 13, 2024 | Cat | Domestic Longhair | Velagliflozin Proline Monohydrate | Hiding; Adipsia; Vocalisation; Ketosis; Ketonuria | Outcome Unknown |
| Dec 13, 2024 | Cat | Domestic Shorthair | Buprenorphine | Tremor; Hyperactivity; Appetite disorder NOS; Dilated pupils; Behavioural dis... | Ongoing |
| Dec 13, 2024 | Cat | Cat (unknown) | Mirtazapine | Lack of efficacy - NOS | Outcome Unknown |
| Dec 12, 2024 | Cat | Domestic Longhair | Frunevetmab | Pruritus; Application site erythema; Application site alopecia; Skin scab | Ongoing |
| Dec 12, 2024 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Hypoglycaemia | Outcome Unknown |
| Dec 12, 2024 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea; Medication error NOS; Administration ... | Ongoing |
| Dec 12, 2024 | Cat | Domestic Longhair | Robenacoxib | Pruritus; Application site erythema; Application site alopecia; Skin scab | Ongoing |
| Dec 12, 2024 | Cat | American Shorthair | Methimazole | Vomiting bile; Oral bleeding; Death; Sickness | Died |
| Dec 12, 2024 | Cat | Domestic Shorthair | Praziquantel; Emodepside | Vomiting | Recovered/Normal |
| Dec 12, 2024 | Cat | Domestic Shorthair | Cefovecin | Intentional misuse; Lack of efficacy - NOS; Vomiting; Decreased appetite; Fre... | Ongoing |
| Dec 12, 2024 | Cat | Domestic Shorthair | Frunevetmab | Skin scab | Ongoing |
| Dec 12, 2024 | Cat | Domestic Shorthair | Bexagliflozin | Hypoglycaemia; Not himself/herself; Decreased haematocrit; Weight loss; Monoc... | Ongoing |
| Dec 12, 2024 | Cat | Cat (unknown) | Molidustat Sodium | Decreased packed cell volume (PCV) | Ongoing |
| Dec 12, 2024 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Increased skin sensitivity; Odor, Abnormal; Solution, Abnormal | Outcome Unknown |
| Dec 12, 2024 | Cat | Domestic Longhair | Fluralaner/Moxidectin Spot-On | Scratching; Localised hair loss | Ongoing |
| Dec 12, 2024 | Cat | Domestic Shorthair | Mirtazapine | Ataxia; Tachypnoea; Lethargy (see also Central nervous system depression in N... | Outcome Unknown |
| Dec 12, 2024 | Cat | Domestic Longhair | Velagliflozin Proline Monohydrate | Ketosis; General illness; Diabetic ketoacidosis | Outcome Unknown |
| Dec 12, 2024 | Cat | Domestic Shorthair | Buprenorphine | Dysphoria; Ataxia; Disorientation; Mydriasis | Recovered/Normal |
| Dec 12, 2024 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Ketosis | Outcome Unknown |
| Dec 12, 2024 | Cat | Domestic Shorthair | Robenacoxib | Decreased appetite; Lethargy (see also Central nervous system depression in N... | Ongoing |
| Dec 12, 2024 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Foaming at the mouth; Accidental exposure | Outcome Unknown |
| Dec 12, 2024 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Lack of efficacy - NOS | Outcome Unknown |
| Dec 12, 2024 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Ketosis | Outcome Unknown |
| Dec 12, 2024 | Cat | Domestic Mediumhair | Maropitant Citrate | Vomiting; Vocalisation; Pain NOS; Lethargy (see also Central nervous system d... | Recovered/Normal |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.